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Clinics and pathology 
Disease 
Non Hodgkin lymphoma (NHL) 
Epidemiology 
Four cases to date: a follicular mixed cell lympho-ma 
in a 78-year-old female patient, a grade 3B follicuar 
lymphoma in a female patient, a gastric lymphoma, and 
a diffuse large B-cell lymphoma (DLCL) (Yunis et al., 
1984; Bosga-Bouwer et al., 2003; Chen et al., 2006; 





There was a complex karyotype, including a 
t(14;18)(q32;q21), +15, and other anomalies in one 
case (Yunis et al., 1984), and also a complex karyotype 
in an other case (Bosga-Bouwer et al., 2003); data is 
missing in the two other cases. 





706 amino acids; composed of a NH2-term BTB/POZ 
domain (amino acids 1-130 (32-99 according to Swiss-
Prot)) which mediates homodi-merization and protein-
protein interactions with other corepressors (including 
HDAC1 and NCOR2/ SMRT) to constitute a large  
repressing complex, another transcription repression 
domain (191-386), PEST sequences (300-417) with a 
KKYK motif (375-379), and six zinc finger at the C-
term (518-541, 546-568, 574-596, 602-624, 630-652, 
658-681), responsible for sequence specific DNA 
binding. Transcription repressor; recognizes the 






760 amino acids; composed of an NH2-term 
cytoplasmic domain (amino acids 1-67), a trans-
membrane domain (aa 68-88), and a C term 
extracellular domain (aa 89-706) according to Swiss-
Prot. Cell surface membrane glycoprotein; involved in 
iron homeostasis by regulating cellular iron uptake 
(Dorak, 2008). 




5' TFRC - 3' BCL6, with a breakpoint in BCL6 
between exon 1 and 2 (Yoshida et al., 1999); the 
breakpoint on TFRC was found 288 bp 3' downstream 
of the breakpoint in the other case studied with 
molecular techniques (Chen et al., 2006). 
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